Shares of NCS Multistage Holdings Inc (NASDAQ:NCSM) have been given a consensus recommendation of “Hold” by the ten ratings firms that are covering the company, Marketbeat reports. Three investment analysts have rated the stock with a sell recommendation, four have given a hold recommendation and two have issued a buy recommendation on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $12.33.
A number of research firms recently commented on NCSM. ValuEngine lowered shares of Zosano Pharma from a “buy” rating to a “hold” rating in a research report on Wednesday, May 1st. Piper Jaffray Companies lowered shares of NCS Multistage from an “overweight” rating to a “neutral” rating and set a $3.80 price target on the stock. in a research report on Tuesday, June 25th. Finally, Zacks Investment Research lowered shares of ExlService from a “hold” rating to a “sell” rating in a research report on Wednesday.
In other news, CFO Ryan Hummer bought 50,000 shares of the firm’s stock in a transaction on Monday, June 3rd. The shares were purchased at an average cost of $2.63 per share, with a total value of $131,500.00. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Franklin Myers bought 40,000 shares of the firm’s stock in a transaction on Friday, May 24th. The stock was purchased at an average cost of $2.57 per share, for a total transaction of $102,800.00. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 140,000 shares of company stock worth $364,800. Insiders own 11.90% of the company’s stock.
NASDAQ:NCSM opened at $3.18 on Tuesday. NCS Multistage has a 52 week low of $2.46 and a 52 week high of $17.63. The business’s 50-day simple moving average is $3.03. The company has a debt-to-equity ratio of 0.14, a quick ratio of 3.72 and a current ratio of 5.44.
NCS Multistage (NASDAQ:NCSM) last released its quarterly earnings results on Monday, May 6th. The company reported ($0.04) EPS for the quarter, hitting analysts’ consensus estimates of ($0.04). NCS Multistage had a negative net margin of 101.98% and a negative return on equity of 1.11%. The business had revenue of $52.85 million for the quarter, compared to analyst estimates of $54.65 million. Equities research analysts anticipate that NCS Multistage will post -0.24 earnings per share for the current year.
About NCS Multistage
NCS Multistage Holdings, Inc provides engineered products and support services for oil and natural gas well completions and field development strategies in the United States, Canada, and internationally. The company's products include casing-installed sliding sleeves, downhole frac isolation assemblies, sand jet perforating products, spotfrac systems, ballshift sliding sleeves, airlock casing buoyancy systems, liner hanger systems, and spectrum tracer services.
Featured Story: Producer Price Index (PPI)
Receive News & Ratings for NCS Multistage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCS Multistage and related companies with MarketBeat.com's FREE daily email newsletter.